3-Methyl-N-(4-methylbenzyl)-5-((4-methylpiperidin-1-yl)sulfonyl)benzofuran-2-carboxamide

Catalog No. :
ACYQCT961
CAS No. :
687574-64-7
Molecular Formula :
C24H28N2O4S
Molecular Weight :
440.57

IUPAC Name:3-methyl-N-(4-methylbenzyl)-5-((4-methylpiperidin-1-yl)sulfonyl)benzofuran-2-carboxamide

3-Methyl-N-(4-methylbenzyl)-5-((4-methylpiperidin-1-yl)sulfonyl)benzofuran-2-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Methyl-N-(4-methylbenzyl)-5-((4-methylpiperidin-1-yl)sulfonyl)benzofuran-2-carboxamide
IUPAC Name3-methyl-N-(4-methylbenzyl)-5-((4-methylpiperidin-1-yl)sulfonyl)benzofuran-2-carboxamide
Molecular FormulaC24H28N2O4S
Molecular Weight440.57
SMILESO=C(C1=C(C)C2=CC(S(=O)(N3CCC(C)CC3)=O)=CC=C2O1)NCC4=CC=C(C)C=C4
InChI KeyIZJUMOGESCUUQM-UHFFFAOYSA-N
Synonym2-Benzofurancarboxamide, 3-methyl-N-[(4-methylphenyl)methyl]-5-[(4-methyl-1-piperidinyl)sulfonyl]-
CAS No.687574-64-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACYQCT961 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYQCT961 route product structure diagram
    ACYQCT961687574-64-7
Inquiry

2. ACYQCT961 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYQCT961 route product structure diagram
    ACYQCT961687574-64-7
Inquiry

Comments (0)